<font color="red">Assessment_2</font> <font color="red">of_1</font> <font color="red">acute_2</font> <font color="red">bronchodilator_2</font> <font color="red">effects_2</font> <font color="red">from_1</font> <font color="red">specific_3</font> <font color="red">airway_3</font> <font color="red">resistance_3</font> <font color="red">changes_2</font> in stable COPD patients . 
<br>
<br> BACKGROUND In COPD patients , reversibility is currently evaluated from the changes of <font color="red">forced_2</font> <font color="red">expiratory_2</font> <font color="red">volume_2</font> <font color="red">at_1</font> <font color="red">1s_1</font> <font color="red">(_1</font> <font color="red">ΔFEV1_1</font> <font color="red">)_1</font> and <font color="red">forced_1</font> <font color="red">vital_1</font> <font color="red">capacity_1</font> <font color="red">(_1</font> <font color="red">ΔFVC_1</font> <font color="red">)_1</font> <font color="red">._1</font> By <font color="red">lowering_1</font> <font color="red">peripheral_1</font> <font color="red">airway_1</font> smooth muscle tone , bronchodilators should <font color="red">decrease_1</font> <font color="red">dynamic_2</font> <font color="red">hyperinflation_2</font> <font color="red">,_2</font> <font color="red">gas_2</font> <font color="red">trapping_2</font> <font color="red">,_2</font> <font color="red">and_2</font> <font color="red">possibly_2</font> <font color="red">dyspnea_2</font> <font color="red">at_1</font> <font color="red">rest_1</font> <font color="red">._1</font> Hence , we hypothesize that <font color="red">specific_1</font> <font color="red">airway_1</font> <font color="red">resistance_1</font> <font color="red">changes_1</font> <font color="red">(_1</font> <font color="red">ΔsRAW_1</font> <font color="red">)_1</font> should better characterize the <font color="red">acute_1</font> <font color="red">response_1</font> <font color="red">to_1</font> <font color="red">bronchodilators_1</font> <font color="red">._1</font> 
<br> METHODS On two days , 60 COPD patients underwent <font color="red">dyspnea_2</font> <font color="red">evaluation_2</font> <font color="red">(_2</font> <font color="red">VAS_2</font> <font color="red">score_2</font> <font color="red">)_2</font> <font color="red">and_1</font> <font color="red">pulmonary_2</font> <font color="red">function_2</font> <font color="red">testing_1</font> at baseline and one hour after placebo or 300μg indacaterol administration . 
<br> RESULTS <font color="red">Spirographic_4</font> <font color="red">and_4</font> <font color="red">ΔsRAW_4</font> <font color="red">-_4</font> <font color="red">based_4</font> <font color="red">criteria_4</font> <font color="red">identified_1</font> <font color="red">as_1</font> <font color="red">responders_1</font> 24 and 45 patients , respectively . <font color="red">ΔsRAW_3</font> correlated with changes of <font color="red">intrathoracic_4</font> <font color="red">gas_4</font> <font color="red">volume_4</font> <font color="red">(_1</font> <font color="red">ΔITGV_1</font> <font color="red">)_1</font> ( r=0.61 ; p<0.001 ) , <font color="red">residual_5</font> <font color="red">volume_5</font> <font color="red">(_1</font> <font color="red">ΔRV_2</font> <font color="red">)_2</font> ( r=0.60 ; p<0.001 ) , <font color="red">ΔFVC_3</font> ( r=0.44 ; p=0.001 ) , and <font color="red">ΔVAS_2</font> ( r=0.73 ; p<0.001 ) , while <font color="red">ΔFEV1_3</font> correlated only with <font color="red">ΔFVC_3</font> ( r=0.34 ; p=0.008 ) . Significant differences in terms of <font color="red">ΔITGV_3</font> <font color="red">(_1</font> <font color="red">p=0.002_1</font> <font color="red">)_1</font> <font color="red">,_1</font> <font color="red">ΔRV_3</font> <font color="red">(_1</font> <font color="red">p=0.023_1</font> <font color="red">)_1</font> <font color="red">,_1</font> <font color="red">and_1</font> <font color="red">ΔVAS_3</font> ( p<0.001 ) occurred only if patients were stratified according to <font color="red">ΔsRAW_2</font> <font color="red">._2</font> 
<br> CONCLUSIONS In assessing the <font color="red">acute_1</font> <font color="red">functional_2</font> <font color="red">effect_2</font> <font color="red">of_2</font> <font color="red">bronchodilators_2</font> <font color="red">,_2</font> <font color="red">ΔsRAW_2</font> <font color="red">-_2</font> <font color="red">based_1</font> <font color="red">criterion_1</font> is preferable to <font color="red">FEV1-FVC_3</font> <font color="red">-_2</font> <font color="red">based_1</font> <font color="red">criteria_1</font> <font color="red">,_1</font> being more closely related to <font color="red">bronchodilator_2</font> <font color="red">-_2</font> <font color="red">induced_2</font> <font color="red">improvements_2</font> <font color="red">of_1</font> <font color="red">lung_1</font> <font color="red">mechanics_1</font> <font color="red">and_1</font> <font color="red">dyspnea_1</font> at rest .